4.5 Interaction with other medicinal products and other forms of interaction  
 Pharmacokinetic interactions 
 No interaction studies have been performed with regdanvimab.  
 Regdanvimab is a monoclonal antibody, which is not renally excreted or metabolised by cytochrome P450 enzymes; therefore, interactions with concomitant medicinal products that are renally excreted or that are substrates, inducers, or inhibitors of cytochrome P450 enzymes are considered unlikely. 
 Pharmacod ynamic interactions 
 No interaction studies have been performed.  
 
